The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Alzheimer’s Disease: Epidemiology and Clinical Progression
Open accessAbstract
Alzheimer's disease (AD) is prevalent throughout the world and is the leading cause of dementia in older individuals (aged ≥ 65 years). To gain a deeper understanding of the recent literature on the epidemiology of AD and its progression, we conducted a review of the PubMed-indexed literature (2014-2021) in North America, Europe, and Asia. The worldwide toll of AD is evidenced by rising prevalence, incidence, and mortality due to AD-estimates which are low because of underdiagnosis of AD. Mild cognitive impairment (MCI) due to AD can ultimately progress to AD dementia; estimates of AD dementia etiology among patients with MCI range from 40% to 75% depending on the populations studied and whether the MCI diagnosis was made clinically or in combination with biomarkers. The risk of AD dementia increases with progression from normal cognition with no amyloid-beta (Aβ) accumulation to early neurodegeneration and subsequently to MCI. For patients with Aβ accumulation and neurodegeneration, lifetime risk of AD dementia has been estimated to be 41.9% among women and 33.6% among men. Data on progression from preclinical AD to MCI are sparse, but an analysis of progression across the three preclinical National Institute on Aging and Alzheimer's Association (NIA-AA) stages suggests that NIA-AA stage 3 (subtle cognitive decline with AD biomarker positivity) could be useful in combination with other tools for treatment decision-making. Factors shown to increase risk include lower Mini-Mental State Examination (MMSE) score, higher Alzheimer's Disease Assessment Scale (ADAS-cog) score, positive APOE4 status, white matter hyperintensities volume, entorhinal cortex atrophy, cerebrospinal fluid (CSF) total tau, CSF neurogranin levels, dependency in instrumental activities of daily living (IADL), and being female. Results suggest that use of biomarkers alongside neurocognitive tests will become an important part of clinical practice as new disease-modifying therapies are introduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The diseases encompass various severe conditions, including neurodegenerative disorders like Alzheimer’s disease (AD) [3, 4] and Parkinson’s disease (PD) [5, 6], as well as traumatic brain injuries (TBI) [7] and spinal cord injuries (SCI) [8].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,168
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Harada, C. N., Love, M. C. N., & Triebel, K. L. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.002 · Cited by 2,649
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412 · cited 2×
“4% of all deaths attributable to dementia in 2016 [31].”
Background
Cited by
Sorted by citations
Items 301–400 of 652
A Predictive ML‐QSAR Approach for Targeting GSK‐3β in Alzheimer's Disease
Maliyakkal, N., Kumar, S., Bhowmik, R., Parmbil, S. K., Aspatwar, A., & Mathew, B. (2025) · Advanced Theory and Simulations · doi:10.1002/adts.202501347 · Cited by 3
Exploring Alzheimer’s diseases with focus on diagnostic strategies targeting amyloid beta 42 (Aβ42)
Chauhan, A., Devi, R., Singh, S., Bhutani, K., Prasad, S., Singh, A., Bhaskar, N., Kumar, S., Saini, A. K., & Thakur, R. (2025) · Discover Neuroscience · doi:10.1186/s13064-025-00217-6 · Cited by 5
Yu, S. P., Gu, X., Jiang, M. Q., Sastry, A., Wu, L., Li, Y., & Wei, L. (2025) · Cells · doi:10.3390/cells14231871 · Cited by 3
Jiao, M., Ding, Z., Huang, C., Xu, Y., 钟宝亮, & Chen, H. (2025) · Behavioral Sciences · doi:10.3390/bs16010040 · Cited by 3
Gut-brain axis targeting postbiotics for treatment of psychological and neurodegenerative disorders
Kamath, S., Sun, Y.-H., Wardill, H. R., & Joyce, P. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108950 · Cited by 3
Lipid metabolic regulation of neuroinflammation in Alzheimer’s disease
Li, T., Guo, K., Ma, Y., Zhao, J., Cao, Y., Zhang, R., Li, X., Wei, J., Ma, Y., Zhu, Z., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1815719 · Cited by 3
Lecanemab use in Chinese patients with Alzheimer's disease: a 12‐month multicenter real‐world study
Wu, H., Chen, Q., Fang, M., Hui⁃dong, T. A. N. G., Liu, H., Liu, J., Zhang, J., Chi, L., Liu, S., Xin, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71702 · Cited by 3
Zhang, J., Xu, X., Zhang, X., Yin, Y., & Wang, J. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03846-w · Cited by 3
Ikeda, M., Toya, S., Manabe, Y., Yamakage, H., & Hashimoto, M. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01419-6 · Cited by 3
Sinha, T., Bokhari, S. F. H., Khan, M. U., Shaheer, M., Amir, M., Zia, B. F., Bakht, D., Javed, M. A., Almadhoun, M. K. I. K., Burhanuddin, M., et al. (2024) · Cureus · doi:10.7759/cureus.58677 · Cited by 3
Saliu, J. A., Olajuyin, A. M., & Monday, O. O. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100437 · Cited by 3
Chu, H., Huang, C., Xie, F., & Guo, Q. (2024) · Neurology and Therapy · doi:10.1007/s40120-024-00666-x · Cited by 3
Ali, A., Ronickom, J. F. A., & Swaminathan, R. (2025) · International Journal of Advances in Engineering Sciences and Applied Mathematics · doi:10.1007/s12572-024-00385-4 · Cited by 3
Early metabolic changes in the brain of Alzheimer’s disease rats are driven by GLAST+ cells
Morrey, W. J., Ceyzériat, K., Amossé, Q., Badina, A. M., Dickie, B., Schießl, I., Tsartsalis, S., Millet, P., Boutin, H., & Tournier, B. B. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251318923 · Cited by 3
Wang, H. (2025) · American Journal of Translational Research · doi:10.62347/yopp4162 · Cited by 3
Predictors of white matter hyperintensities in the elderly Congolese population
Yohe, E. O., Alonso, Á., Drane, D. L., Patel, S. S., Schwinne, M., Epenge, E., Gikelekele, G., Esambo, H., Kavugho, I., Tshengele, N., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1491477 · Cited by 3
Ojo, O. A., Maduakolam-Aniobi, T. C., Gyebi, G. A., Soyinka, T. O., Ejiogu, O. F., Ojo, A. B., Alruwaili, M., Ali, N. H., Alnaaim, S. A., Alsfouk, B. A. A., et al. (2025) · Nutrire · doi:10.1186/s41110-025-00335-5 · Cited by 3
Enhancing Alzheimer’s Disease Diagnosis: Insights from MLP and 1D CNN Models
Bandeira, J., & Fagundes, R. (2025) · Anais do Simpósio Brasileiro de Sistemas de Informação (SBSI) · doi:10.5753/sbsi.2025.246492 · Cited by 3
Caldero-Escudero, E., Romero-Sanz, S., Álvarez-Illera, P., de la Fuente, S., García-Casas, P., Fonteríz, R. I., Montero, M., Álvarez, J., & Domingo, J. S. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167946 · Cited by 3
Bao, S., Zheng, F., Jiang, L., Wang, Q., & Lyu, Y. (2025) · BMC Medical Imaging · doi:10.1186/s12880-025-01836-5 · Cited by 3
Liu, T., & Li, X. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70460 · Cited by 3
Fan, Y., Lin, S., Chou, C., & Bai, C. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043065 · Cited by 3
Liu, G., Lyu, X., & Wang, V. (2023) · Studies in health technology and informatics · doi:10.3233/shti230893 · Cited by 3
Cimiotti, C. G. V., Paganetti, P., Rossi, S., Soldini, E., & Sacco, L. (2023) · NeuroSci · doi:10.3390/neurosci4040026 · Cited by 3
Risk factors for cognitive decline in non-demented elders with amyloid-beta positivity
Wang, A.-Y., Hu, H., Huang, L.-Y., Xiao, C.-Y., Li, Q., Tan, L., & Hu, H. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01554-0 · Cited by 3
Factors Associated with Increased Burden of Caregivers of People with Dementia with Lewy Bodies
Toya, S., Hashimoto, M., Manabe, Y., Yamakage, H., & Ikeda, M. (2024) · Geriatrics · doi:10.3390/geriatrics9050115 · Cited by 3
Yang, Y., Liu, X., Li, W., Yuan, S., Wu, X. C., & Guo, R. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.108049 · Cited by 3
Wen, J., Hu, J., Yang, X., Luo, F., & Zou, G. (2025) · Current Alzheimer Research · doi:10.2174/0115672050399031250623062112 · Cited by 3
Du, Y., Zhang, Y., Diao, J., Fu, P., Jiang, R., Wang, P., Yang, H., Zheng, X., Zhang, L., Bi, J., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202301485r · Cited by 2
Neuroprotective properties of taurine
Cieślak, M., Karmańska, A., Kaźmierczak-Barańska, J., Korycka, M., & Karwowski, B. T. (2024) · Farmacja Polska · doi:10.32383/farmpol/181132 · Cited by 2
Altıntaş, E., Luyat, M., Gallouj, K., Hülür, G., & Haj, M. E. (2024) · Applied Neuropsychology Adult · doi:10.1080/23279095.2024.2367102 · Cited by 2
Hearing Loss and Alzheimer Disease
Stadio, A. D., Hamiter, M. J., Roccamatisi, D., & Lalwani, A. K. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_526 · Cited by 2
Gao, F., Xu, W., Xiao, Y., Jiang, W., Chen, M., Liu, Z., Zhang, P., Yang, T., Qian, Z., & Gao, K. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.157496 · Cited by 2
Impact of diabetes mellitus on the risk of Alzheimer’s disease: a mendelian randomization study
Wang, W., Zhang, J., Zhang, M., Zhang, C., Liu, H., Li, W., & Fan, Y. (2024) · BMC Neurology · doi:10.1186/s12883-024-03955-y · Cited by 2
Cordia dichotoma G. Forst fruit prophylactic against Alzheimer's risk factors: in vitro study
Ibrahim, F. M., Ibrahim, A. Y., Amer, H. M., Ramadan, M. F., & Mohammed, R. S. (2024) · RENDICONTI LINCEI · doi:10.1007/s12210-024-01283-4 · Cited by 2
Heat shock protein and Alzheimer’s disease: an updated systematic review
Raza, H., Ali, A., Kumar, A., Adnan, F., Shah, S. A. W., Ghazanfar, S., Roshan, F. N. U., Shamim, Z., Opare, A. D., & Tanveer, F. S. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002887 · Cited by 2
Alnaim, M., Shanabah, W. M. A., Alamer, L. A., Alduraywish, W. A., Alkhitrish, M., Alshuaibi, W., Almulla, S. A., Almulhim, L. A. A., Sagoor, H. A. A., & Alokley, A. A. (2025) · Annals of African Medicine · doi:10.4103/aam.aam_163_24 · Cited by 2
Zhao, X., Chen, L., Ma, L., Liu, X., Cao, Z., Chen, X., & Hu, L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00975 · Cited by 2
Trends and research focus on autophagy in Alzheimer's disease (2003–2023): A bibliometric study
Wang, T., Jiang, H., Zheng, R., Zhang, C., Xiu-mei, M., & Liu, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251336442 · Cited by 2
Alcohol Use Disorder and Dementia: A Scoping Review
Petrović, Z. K., Peraica, T., & Kozarić‐Kovačić, D. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00668-1 · Cited by 2
Kumagai, S., Park, H., Chen, S., & Yamasaki, T. (2025) · Brain Sciences · doi:10.3390/brainsci15070682 · Cited by 2
Alrikabi, A., Allahyani, W., Shaghath, A., Alrashdi, J., Almoqhem, R., Alasmari, F. F., Al-Qerem, W. A., & Albasher, G. I. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1634601 · Cited by 2
Lima, S. M., Moreira, G. D. C., Lins, A. C. D. A., Peixoto, A. L. D. A., & da Silva, J. C. (2025) · Research Society and Development · doi:10.33448/rsd-v14i8.49395 · Cited by 2
An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease
Samin, K. M. S., & Sadek, S. (2025) · Integrative Biomedical Research · doi:10.25163/biomedical.9110244 · Cited by 2
Unraveling the complexity of chronic diseases: an introductory exploration
Prajapati, C., Singh, P., Nand, S., & Singh, S. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33877-9.00005-7 · Cited by 2
Precision therapeutics for Alzheimer’s disease
Priyanka, S., Manjari, T., Hemalatha, S., Ambika, S., Yilmaz, B. N., Aktürk, B., Arısan, E. D., Kumari, A., & Manojkumar, Y. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.08.011 · Cited by 2
Fazio‐Eynullayeva, E., Mystkowski, P., Lv, L., Aly, A., Cotton, S. E., Grant, N., Johnson, W., & Mattke, S. (2025) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175251375378 · Cited by 2
Huang, Y., Han, M. H., Fu, Y., Wang, G., Kong, L., Mo, J., Cao, D., Chu, Z., & Li, W. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178349 · Cited by 2
Yang, Y., Atiya, A., Alrouji, M., Alshammari, M. S., Sharaf, S. E., Yadav, D. K., Alshehri, S. A., Shahwan, M. J., & Shamsi, A. (2025) · Journal of Chemistry · doi:10.1155/joch/2537269 · Cited by 2
Song, J., Lu, Q., Zhang, S., He, C., Zhang, T., Yan, H., Han, Y., Wang, H., Liu, H., Zhao, Z., et al. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121636 · Cited by 2
Salman, B., Haidar, R., Faour, V., Ali, W. A., Aridi, L., Harb, F., Azar, S. T., Khattar, Z. A., & Ghadieh, H. E. (2025) · Health Sciences Review · doi:10.1016/j.hsr.2025.100251 · Cited by 2
Shah, M., Patel, K., Kulkarni, U., Yadav, M. R., Patel, A., & Nagani, A. (2026) · Molecular Diversity · doi:10.1007/s11030-025-11458-2 · Cited by 2
Epigenomics in Understanding Racial Disparities of Alzheimer’s Disease and Related Dementias
Subasinghe, K., Jones, H., Barber, R. C., & Phillips, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020739 · Cited by 2
Reichau, K., Crouzier, L., Poeta, E., Gehrig, T., Schaller, E., Zvejniece, L., Meunier, J., Sotriffer, C., Monti, B., Maurice, T., et al. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00921 · Cited by 2
Handajani, Y. S., Turana, Y., Hengky, A., & Kristian, K. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261415596 · Cited by 2
Neuronal PPP2R5C in plasma is a potential biomarker for early diagnosis of Alzheimer’s disease
Luo, S., Liu, H., Xiao, T., Li, Y., Liu, X., Xiao, X., Liao, X., Liu, Y., Zhou, Y., Wang, J.-L., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102631 · Cited by 3
Cerebral glucose uptake and cognitive functions: A phenome-wide Mendelian randomization study
Ueda, M., Suzuki, T., Yoshimizu, T., Konuma, T., Maekawa, M., Sasase, T., Initiative, A. D. N., & Nishiu, J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261418310 · Cited by 2
Şener, H., Ozer, F., Polat, O. A., Ogurlu, B., Sönmez, H. K., Gültekin, M., & Horozoğlu, F. (2026) · Documenta Ophthalmologica · doi:10.1007/s10633-026-10089-8 · Cited by 2
Chen, Y., Zhou, X., Wang, K., Feng, H., Tian, B., Tang, Y., Zhu, X., & Sun, Z. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1779257 · Cited by 2
Lin, Y., Tao, Y., He, Z., Wang, H., Zheng, Y., & Jin, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1788223 · Cited by 2
Zafari, R., Kamroo, A., Taherkhani, T., Nabizdeh, F., & Aarabi, M. H. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.05.010 · Cited by 3
Liu, C., Zhu, Z., Lin, H., Bush, W. S., Jenq, R. R., Cominelli, F., Pillai, J. A., Haines, J. L., Zhu, X., Xu, R., et al. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1735332 · Cited by 2
Menezes, J., Barbosa, M. I. A., & Rodrigues, P. M. (2026) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2026.111143 · Cited by 2
Kakorina, E. P., Samorodskaya, I. V., & Константиновна, Ч. Т. (2023) · Russian Journal of Forensic Medicine · doi:10.17816/fm753 · Cited by 2
Doostdar, A., Nabovati, P., Asharlous, A., & Khabazkhoob, M. (2023) · International Journal of Ophthalmology · doi:10.18240/ijo.2023.04.17 · Cited by 2
Rezapour-Nasrabad, R., Heydari, M., Moqaddam, S. F. M., Piri, S., Moghimi, E. S., & Rustaee, S. (2023) · Galen Medical Journal · doi:10.31661/gmj.v12i.3205 · Cited by 2
Thatha, V. N. (2024) · Journal of Electrical Systems · doi:10.52783/jes.2849 · Cited by 2
He, C., Hu, X., Wang, M., Yin, X., Zhan, M., Li, Y., Sun, L., Du, Y., Chen, Z., Wang, H., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1352129 · Cited by 2
Egln3 expression in microglia enhances the neuroinflammatory responses in Alzheimer’s disease
Guan, J., Wu, P., Liu, M., Jiang, C., Meng, X., Wu, X., Lu, M., Fan, Y., & Gan, L. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.022 · Cited by 3
Rocking during sleep reduces motor deficits and beta-amyloid levels in an Alzheimer’s mouse model
Zhang, L., Santoni, L., Ngo, N. A., Simayi, R., Ficiarà, E., de Vivo, L., & Bellesi, M. (2025) · iScience · doi:10.1016/j.isci.2025.112036 · Cited by 2
Umoh, I., Xia, X., Winblad, B. G., Aye, S., Aho, E., Rhodius‐Meester, H. F. M., & Jönsson, L. (2025) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000544801 · Cited by 2
Shi, N., Bakulski, K. M., Burke, J. F., & Brouwer, A. F. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251324236 · Cited by 2
A Comprehensive Comparison Between ANNs and KANs For Classifying EEG Alzheimer’s Data
Sunkara, A., Sattiraju, S., Kumar, A. P. S., Kanjiani, Z., & Anumala, H. (2024) · IEEE MIT Undergraduate Research Technology Conference (URTC) · doi:10.1109/urtc65039.2024.10937564 · Cited by 2
Aly, H. F., Fouad, G. I., Khalil, W. K. B., Kamel, N. N., El-Rigal, N. S., Ahmed, K. A., Taha, D. A., Shalaby, M. B., El‐Karim, S. S. A., Baker, D. H. A., et al. (2025) · Neurological Research · doi:10.1080/01616412.2025.2520021 · Cited by 2
Therapeutic Modalities Targeting Tau Protein in Alzheimer’s Disease
Schreiner, T. G., Iacob, L., Vasilache, C., & Schreiner, O. D. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2030032 · Cited by 2
Jeong, H., Kang, D. H., Kim, J., Lim, J., & Lee, H. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251385901 · Cited by 2
Bıyıklıoğlu, Z., Seyhan, G., Öztürmen, B. A., Kolci, K., Reis, R., & Barut, B. (2023) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2023.122926 · Cited by 2
Kolakemar, A., Gangachannaiah, S., Holla, S. N., Mohandas Rao, K. G., Shenoy, S., Chinta, R., Mehta, C. H., & Nayak, U. Y. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00029 · Cited by 2
Gohil, N. V., Fuentes-Gandara, F., Gohil, H., Gurajala, S., Innocent, D. C., Tesfaye, T., & Praticò, D. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-240057 · Cited by 2
Xu, Y., Wei, H., Du, R., Wang, R., Zhu, Y., Zhao, T., Zhu, X., & Li, Y. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00635-y · Cited by 2
Mishra, S., Stany, B. K., Kumari, A., & Rao, K. V. B. (2025) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2025.103559 · Cited by 2
The Link Between Oxysterols and Gut Microbiota in the Co-Dysfunction of Cognition and Muscle
Ju, M., Feng, W., Guo, Z., Yang, K., Wang, T., Yu, H., Qi, C., Liu, M., Tao, J., & Xiao, R. (2025) · Nutrients · doi:10.3390/nu17071277 · Cited by 2
Khosroabadi, Z., Niazmand, A., Mousavi, S. R., Hosseini, N., Bagheri, N., Chitsaz, A., & Salehi, M. (2025) · Current Alzheimer Research · doi:10.2174/0115672050381537250422075255 · Cited by 2
Liu, C., Wang, X., Xu, W., Yu, S., Zhang, Y., Xu, Q., & Tan, X. (2025) · Pharmaceuticals · doi:10.3390/ph18070977 · Cited by 2
Zhang, H., Zhang, J., Hsu, C. L., Hui, E. S. K., Tse, K., Mak, H. K., & Shum, D. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf278 · Cited by 2
Bhratee, A., Kumar, M., Alam, M. R., Anand, P., & Singh, S. (2023) · Current Pharmacology Reports · doi:10.1007/s40495-023-00325-z · Cited by 2
Detection of mild cognitive impairment based on attention mechanism and parallel dilated convolution
Wang, T., Ding, Z., Yang, X., Chen, Y., Liu, Y., Kong, X., & Sun, Y. (2024) · PeerJ Computer Science · doi:10.7717/peerj-cs.2056 · Cited by 2
Characterization of a new set of monoclonal β-amyloid antibodies
Che, H.-Y., Ai, J.-Q., Chen, Y., Cai, X.-L., Wang, Y., Jiang, J., Zhang, Q., Tu, T., Tu, E., Che, C., et al. (2022) · Human Brain · doi:10.37819/hb.001.001.0206 · Cited by 2
Self-citationGraphene as the basis of biological sensors for the diagnosis of neurodegenerative dementia
Vorobev, S. V., Ternovykh, I. К., Lebedev, A. A., Smirnov, A. N., Усиков, А. С., & Лебедев, С. П. (2022) · Russian Military Medical Academy Reports · doi:10.17816/rmmar111884 · Cited by 2
Key genes associated with Alzheimer's disease and periodontitisPreprint
Zhou, K., Wang, L., Wu, L., Wu, Q. Y., Zhu, L., Yang, X., & Li, D. (2022) · Research Square · doi:10.21203/rs.3.rs-2230514/v1 · Cited by 2
Development and initial evaluation of a conversational agent for Alzheimer’s diseasePreprint
Castano-Villegas, N., Llano, I., Villa, M. C., Martinez, J., Zea, J., Urrea, T., Bañol, A. M., Bohorquez, C., & Martinez, N. (2024) · medRxiv · doi:10.1101/2024.09.04.24312955 · Cited by 2
Early Screening for Alzheimer's Disease Based on OCT Image Classification
Li, W., Wu, S., Chen, Y., & Wang, X. (2024) · International Conference on Advanced Algorithms and Control Engineering (ICAACE) · doi:10.1109/icaace61206.2024.10548041 · Cited by 1
Detecting Alzheimer's Disease (Gender-Based) Using Different Machine Learning Approaches
Negi, H. S., Indu, R., Dimri, S. C., Kumar, B., Bisht, N., & Gupta, A. (2025) · International Computer Science Conference · doi:10.1109/icsc64553.2025.10968947 · Cited by 1
Ren, T., Yuchi, Y., Feng, L., Wang, X., Liao, W., Tian, Z., Zhang, H., Tian, Y., Li, Y., & Wang, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1566659 · Cited by 1
Zanini, L., D’Antonio, F., Vita, A. D., Talarico, G., Monti, M. S., Panigutti, M., Bruno, G., Spitoni, G. F., & Guariglia, C. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251362249 · Cited by 1
Pinkley, N., Banik, U., Anam, N., Oza, A., Ledford, K. J., & Sharma, B. (2026) · Sensors · doi:10.3390/s26061999 · Cited by 1
Recchia, D., Michel Raymond, A., Berticat, C., & Artéro, S. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100657 · Cited by 1
Gerlando, R. D., Dragoni, F., Rizzo, B., Ferrari, R. R., Zardini, E., Ramusino, M. C., Perini, G., Costa, A. C., Poloni, T. E., Pansarasa, O., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0350 · Cited by 1
Cao, D., Zhang, S., Zhang, Y., Shao, M., Yang, Q., & Wang, P. (2024) · BMC Cancer · doi:10.1186/s12885-024-12787-5 · Cited by 1
Regional analysis of APOE polymorphism in Alzheimer’s disease in Spain
Pardo-Pérez, I., Sánchez-Valdeón, L., Gallego, A. G., Estébanez, B., Verdejo, I. C., Fernández-Fernández, J. A., Méndez-Martínez, C., & Bello-Corral, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-98323-2 · Cited by 1
Metadata
- Authors
- Tahami Monfared, A. A., Byrnes, M. J., White, L. A., & Zhang, Q.
- Affiliations
- Eisai (United States) (US)
- Venue
- Neurology and Therapy
- Published
- 2022-03-14
- Volume
- 11
- Issue
- 2
- Pages
- 553-569
- ISSN
- 2193-6536 (ISSN-L)
- 2193-8253
- PMC
- PMC9095793
- OpenAlex
- W4221041873
- Cited by
- 629
- References
- 74
- Citations by year
- 2026: 161 · 2025: 208 · 2024: 161 · 2023: 80 · 2022: 19
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neurology and Therapy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Eisai
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, clinical progression, mild cognitive impairment, amyloid-beta deposition, neurodegeneration, preclinical Alzheimer's disease, disease risk factors, APOE ε4, white matter hyperintensities, entorhinal cortex atrophy, cerebrospinal fluid biomarkers, tau protein, neurogranin, dementia mortality, underdiagnosis, disease-modifying therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
